Yield10 Bioscience Inc

General ticker "YTEN" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $277.1K

Yield10 Bioscience Inc does not follow the US Stock Market performance with the rate: -39.6%.

Estimated limits based on current volatility of 17.6%: low 0.33$, high 0.47$

Factors to consider:

  • US accounted for 100.0% of revenue in the fiscal year ended 2022-12-31
  • Earnings for 6 months up through Q2 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [5.92$, 20.94$]
  • 2024-12-30 to 2025-12-30 estimated range: [4.38$, 13.02$]

Financial Metrics affecting the YTEN estimates:

  • Negative: Non-GAAP EPS, $ of -43.68 <= 0.10
  • Negative: Operating profit margin, % of -99.59 <= 1.03
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -84.58 <= 2.35
  • Negative: Industry operating profit margin (median), % of -98.30 <= 2.14
  • Negative: Industry earnings per price (median), % of -26.04 <= 1.31

Similar symbols

Short-term YTEN quotes

Long-term YTEN plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.61MM $0.45MM $0.06MM
Operating Expenses $12.31MM $13.90MM $14.48MM
Operating Income $-11.69MM $-13.45MM $-14.42MM
Non-Operating Income $0.70MM $0.04MM $-0.04MM
R&D Expense $6.20MM $7.75MM $8.32MM
Income(Loss) $-10.99MM $-13.41MM $-14.46MM
Taxes $0.04MM $0.16MM $0.00MM
Profit(Loss) $-11.03MM $-13.57MM $-14.46MM
Stockholders Equity $16.03MM $4.40MM $-2.48MM
Assets $20.41MM $8.09MM $3.91MM
Operating Cash Flow $-9.25MM $-11.40MM $-10.07MM
Capital expenditure $0.19MM $0.15MM $0.05MM
Investing Cash Flow $-4.58MM $8.52MM $1.95MM
Financing Cash Flow $15.75MM $-0.04MM $6.87MM
Earnings Per Share* $-55.95 $-66.25 $-43.66

* EPS are Split Adjusted, recent splits may be reflected with a delay.